Apidemia IVS: Financial statements 2017
CVR: 37503312
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Apidemia IVS (CVR 37503312) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 242,557 and a net result of DKK -383,675 compared with DKK -261,932 the year before. Equity in the 2017 report amounted to DKK -645,606. The company had 2 employees in the financial year.
- Gross Profit
- DKK 242,557
- Profit/Loss
- DKK -383,675
- Equity
- DKK -645,606
- Total Assets
- DKK 118,568
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 243 t. | -384 t. | -646 t. | 2 |
| 2016 | - | -105 t. | -262 t. | -262 t. | 1 |
Official annual report
Keep an eye on Apidemia IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Apidemia IVS has published its interim report for the period March 1, 2016 – December 31, 2016.
About Apidemia IVS
Apidemia IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 10 November 2022. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company was previously named dotboost IVS. The company has 2 employees (2021). In 2020, the company reported a gross profit of DKK 161,017 and a net result of DKK -201,443 compared with DKK 59,896 the year before. Equity in the 2020 report amounted to DKK -1,142,472.